NASDAQ:ADUS - Nasdaq - US0067391062 - Common Stock - Currency: USD
ADDUS HOMECARE CORP
NASDAQ:ADUS (2/4/2025, 8:25:14 PM)
After market: 123.02 0 (0%)123.02
-2.07 (-1.65%)
The current stock price of ADUS is 123.02 USD. In the past month the price decreased by -1.26%. In the past year, price increased by 30.54%.
Why Quality Investors May Find ADDUS HOMECARE CORP (NASDAQ:ADUS) Attractive.
DaVita stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 64 to 72.
JMP Securities begins coverage of Addus HomeCare Corp with a $150 price target, highlighting expansion plans, strategic acquisitions, and strong revenue growth.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 10.66 | 81.07B | ||
CVS | CVS HEALTH CORP | 8.87 | 70.91B | ||
LH | LABCORP HOLDINGS INC | 17.11 | 20.63B | ||
DGX | QUEST DIAGNOSTICS INC | 18.31 | 18.23B | ||
DVA | DAVITA INC | 19.97 | 14.54B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 176.57 | 14.45B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 14.89 | 14.42B | ||
HIMS | HIMS & HERS HEALTH INC | 95.11 | 9.14B | ||
CHE | CHEMED CORP | 24.34 | 8.35B | ||
CRVL | CORVEL CORP | 26.46 | 6.40B | ||
GH | GUARDANT HEALTH INC | N/A | 5.83B | ||
OPCH | OPTION CARE HEALTH INC | 25.97 | 5.26B |
Addus HomeCare Corp. engages in the provision of in-home personal care services. The company is headquartered in Frisco, Texas and currently employs 6,059 full-time employees. The company went IPO on 2009-10-28. Its segments include Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The services it provides include assistance with bathing, grooming, feeding and dressing, medication reminders and others. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and related services for their families. The Hospice services it provides include palliative nursing care, social work, spiritual counseling, homemaker services and bereavement counseling. Its Home Health segment provides services that are medical in nature to individuals who may require assistance during an illness or after hospitalization and includes skilled nursing and physical, occupational and speech therapy.
ADDUS HOMECARE CORP
6303 Cowboys Way, Suite 600
Frisco TEXAS 75034 US
CEO: R. Dirk Allison
Employees: 20453
Company Website: https://addus.com/
Investor Relations: https://addus.gcs-web.com
Phone: 14695358200
The current stock price of ADUS is 123.02 USD.
The exchange symbol of ADDUS HOMECARE CORP is ADUS and it is listed on the Nasdaq exchange.
ADUS stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ADUS, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ADUS.
ADUS does not pay a dividend.
The PE ratio for ADUS is 23.75. This is based on the reported non-GAAP earnings per share of 5.18 and the current share price of 123.02 USD.
The outstanding short interest for ADUS is 3.05% of its float.
ChartMill assigns a technical rating of 4 / 10 to ADUS. When comparing the yearly performance of all stocks, ADUS is one of the better performing stocks in the market, outperforming 78.48% of all stocks.
ChartMill assigns a fundamental rating of 7 / 10 to ADUS. ADUS gets an excellent profitability rating and is at the same time showing great financial health properties.
Over the last trailing twelve months ADUS reported a non-GAAP Earnings per Share(EPS) of 5.18. The EPS decreased by 20.47% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 6.5% | ||
ROA | 6.39% | ||
ROE | 7.77% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 84% to ADUS. The Buy consensus is the average rating of analysts ratings from 18 analysts.
For the next year, analysts expect an EPS growth of 16.38% and a revenue growth 8.53% for ADUS